Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled human insulin vs insulin aspart in diabetes and COPD
NCT00472953Phase 3Terminated
- Sponsor
- Novo Nordisk
- Start
- May 2007
- Primary completion
- Mar 2008
- Modality
- Biologic
- Countries
- 7
01
Overview
A Phase 3 trial of insulin human in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started May 2007; status: terminated.
02
Drugs
insulin human
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00472953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00472953.